Clinical Trial

PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the safety of the AQUABEAM Robotic System in treating patients with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-09-19; most recent amendment 2024-08-12.
Status change: Recruiting → Active, Not Recruiting 2024-08-12
Status change: Not Yet Recruiting → Recruiting 2023-11-27
Trial Details
NCT Number NCT06054867
Lead Sponsor PROCEPT BioRobotics
Conditions Localized Prostate Cancer
Enrollment 22 participants
Start Date 2024-03-11
Primary Completion 2025-04 (estimated)
Study Completion 2025-04 (estimated)
Updated on ClinicalTrials.gov 2024-08-14